世界の腫瘍プレシジョンメディシン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Oncology Precision Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12525 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、腫瘍プレシジョンメディシンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍プレシジョンメディシンの種類別市場規模（科学、精密診断、デジタルヘルス・情報技術、精密治療）、用途別市場規模（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍プレシジョンメディシンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Agilent Technologies、Almac、ANGLE plc、Asuragen、BGI Group、Bio-Rad Laboratories、BioMérieux、Bristol Myers Squibb、Roche Holding AG、Gilead Sciences、Illumina、Konica Minolta、LabCorp、MDxHealth、Myriad Genetics、Novartis、OPKO Health、Pacific Biosciences、Quest Diagnostics、Qiagen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：科学、精密診断、デジタルヘルス・情報技術、精密治療 ・用途別分析2016年-2026年：乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他 ・腫瘍プレシジョンメディシンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍プレシジョンメディシンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍プレシジョンメディシンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍プレシジョンメディシンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍プレシジョンメディシンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Oncology Precision Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oncology Precision Medicine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oncology Precision Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Oncology Precision Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics

Market segment by Application, can be divided into
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Other Cancer

Market segment by players, this report covers
Abbott Laboratories
Agilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncology Precision Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncology Precision Medicine, with revenue, gross margin and global market share of Oncology Precision Medicine from 2019 to 2021.
Chapter 3, the Oncology Precision Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oncology Precision Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oncology Precision Medicine research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Oncology Precision Medicine
1.2 Classification of Oncology Precision Medicine by Type
1.2.1 Overview: Global Oncology Precision Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oncology Precision Medicine Revenue Market Share by Type in 2020
1.2.3 Applied Sciences
1.2.4 Precision Diagnostics
1.2.5 Digital Health and Information Technology
1.2.6 Precision Therapeutics
1.3 Global Oncology Precision Medicine Market by Application
1.3.1 Overview: Global Oncology Precision Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Global Oncology Precision Medicine Market Size & Forecast
1.5 Global Oncology Precision Medicine Market Size and Forecast by Region
1.5.1 Global Oncology Precision Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oncology Precision Medicine Market Size by Region, (2016-2021)
1.5.3 North America Oncology Precision Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Oncology Precision Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oncology Precision Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Oncology Precision Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oncology Precision Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Precision Medicine Market Drivers
1.6.2 Oncology Precision Medicine Market Restraints
1.6.3 Oncology Precision Medicine Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Oncology Precision Medicine Product and Solutions
2.3.4 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Almac Recent Developments and Future Plans
2.4 ANGLE plc
2.4.1 ANGLE plc Details
2.4.2 ANGLE plc Major Business
2.4.3 ANGLE plc Oncology Precision Medicine Product and Solutions
2.4.4 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ANGLE plc Recent Developments and Future Plans
2.5 Asuragen
2.5.1 Asuragen Details
2.5.2 Asuragen Major Business
2.5.3 Asuragen Oncology Precision Medicine Product and Solutions
2.5.4 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Asuragen Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Oncology Precision Medicine Product and Solutions
2.6.4 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
2.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 BioMérieux
2.8.1 BioMérieux Details
2.8.2 BioMérieux Major Business
2.8.3 BioMérieux Oncology Precision Medicine Product and Solutions
2.8.4 BioMérieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 BioMérieux Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
2.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Oncology Precision Medicine Product and Solutions
2.10.4 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche Holding AG Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Precision Medicine Product and Solutions
2.11.4 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Illumina
2.12.1 Illumina Details
2.12.2 Illumina Major Business
2.12.3 Illumina Oncology Precision Medicine Product and Solutions
2.12.4 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Illumina Recent Developments and Future Plans
2.13 Konica Minolta
2.13.1 Konica Minolta Details
2.13.2 Konica Minolta Major Business
2.13.3 Konica Minolta Oncology Precision Medicine Product and Solutions
2.13.4 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Konica Minolta Recent Developments and Future Plans
2.14 LabCorp
2.14.1 LabCorp Details
2.14.2 LabCorp Major Business
2.14.3 LabCorp Oncology Precision Medicine Product and Solutions
2.14.4 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 LabCorp Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Oncology Precision Medicine Product and Solutions
2.15.4 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 Myriad Genetics
2.16.1 Myriad Genetics Details
2.16.2 Myriad Genetics Major Business
2.16.3 Myriad Genetics Oncology Precision Medicine Product and Solutions
2.16.4 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Myriad Genetics Recent Developments and Future Plans
2.17 Novartis
2.17.1 Novartis Details
2.17.2 Novartis Major Business
2.17.3 Novartis Oncology Precision Medicine Product and Solutions
2.17.4 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Novartis Recent Developments and Future Plans
2.18 OPKO Health
2.18.1 OPKO Health Details
2.18.2 OPKO Health Major Business
2.18.3 OPKO Health Oncology Precision Medicine Product and Solutions
2.18.4 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 OPKO Health Recent Developments and Future Plans
2.19 Pacific Biosciences
2.19.1 Pacific Biosciences Details
2.19.2 Pacific Biosciences Major Business
2.19.3 Pacific Biosciences Oncology Precision Medicine Product and Solutions
2.19.4 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Pacific Biosciences Recent Developments and Future Plans
2.20 Quest Diagnostics
2.20.1 Quest Diagnostics Details
2.20.2 Quest Diagnostics Major Business
2.20.3 Quest Diagnostics Oncology Precision Medicine Product and Solutions
2.20.4 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Quest Diagnostics Recent Developments and Future Plans
2.21 Qiagen
2.21.1 Qiagen Details
2.21.2 Qiagen Major Business
2.21.3 Qiagen Oncology Precision Medicine Product and Solutions
2.21.4 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Precision Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Precision Medicine Players Market Share
3.2.2 Top 10 Oncology Precision Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Oncology Precision Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Precision Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Oncology Precision Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oncology Precision Medicine Revenue Market Share by Application (2016-2021)
5.2 Oncology Precision Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Precision Medicine Revenue by Type (2016-2026)
6.2 North America Oncology Precision Medicine Revenue by Application (2016-2026)
6.3 North America Oncology Precision Medicine Market Size by Country
6.3.1 North America Oncology Precision Medicine Revenue by Country (2016-2026)
6.3.2 United States Oncology Precision Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Oncology Precision Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Oncology Precision Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Precision Medicine Revenue by Type (2016-2026)
7.2 Europe Oncology Precision Medicine Revenue by Application (2016-2026)
7.3 Europe Oncology Precision Medicine Market Size by Country
7.3.1 Europe Oncology Precision Medicine Revenue by Country (2016-2026)
7.3.2 Germany Oncology Precision Medicine Market Size and Forecast (2016-2026)
7.3.3 France Oncology Precision Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oncology Precision Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Oncology Precision Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Oncology Precision Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Precision Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Oncology Precision Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Oncology Precision Medicine Revenue by Region (2016-2026)
8.3.2 China Oncology Precision Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Oncology Precision Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Oncology Precision Medicine Market Size and Forecast (2016-2026)
8.3.5 India Oncology Precision Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oncology Precision Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Oncology Precision Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Precision Medicine Revenue by Type (2016-2026)
9.2 South America Oncology Precision Medicine Revenue by Application (2016-2026)
9.3 South America Oncology Precision Medicine Market Size by Country
9.3.1 South America Oncology Precision Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Oncology Precision Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Oncology Precision Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Precision Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Oncology Precision Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Oncology Precision Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Oncology Precision Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oncology Precision Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Oncology Precision Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Oncology Precision Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oncology Precision Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oncology Precision Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oncology Precision Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oncology Precision Medicine Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Oncology Precision Medicine Product and Solutions
Table 9. Abbott Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Oncology Precision Medicine Product and Solutions
Table 13. Agilent Technologies Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Almac Corporate Information, Head Office, and Major Competitors
Table 15. Almac Major Business
Table 16. Almac Oncology Precision Medicine Product and Solutions
Table 17. Almac Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ANGLE plc Corporate Information, Head Office, and Major Competitors
Table 19. ANGLE plc Major Business
Table 20. ANGLE plc Oncology Precision Medicine Product and Solutions
Table 21. ANGLE plc Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Asuragen Corporate Information, Head Office, and Major Competitors
Table 23. Asuragen Major Business
Table 24. Asuragen Oncology Precision Medicine Product and Solutions
Table 25. Asuragen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BGI Group Corporate Information, Head Office, and Major Competitors
Table 27. BGI Group Major Business
Table 28. BGI Group Oncology Precision Medicine Product and Solutions
Table 29. BGI Group Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
Table 33. Bio-Rad Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 35. BioMérieux Major Business
Table 36. BioMérieux Oncology Precision Medicine Product and Solutions
Table 37. BioMérieux Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 39. Bristol Myers Squibb Major Business
Table 40. Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
Table 41. Bristol Myers Squibb Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 43. Roche Holding AG Major Business
Table 44. Roche Holding AG Oncology Precision Medicine Product and Solutions
Table 45. Roche Holding AG Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 47. Gilead Sciences Major Business
Table 48. Gilead Sciences Oncology Precision Medicine Product and Solutions
Table 49. Gilead Sciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Illumina Corporate Information, Head Office, and Major Competitors
Table 51. Illumina Major Business
Table 52. Illumina Oncology Precision Medicine Product and Solutions
Table 53. Illumina Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Konica Minolta Corporate Information, Head Office, and Major Competitors
Table 55. Konica Minolta Major Business
Table 56. Konica Minolta Oncology Precision Medicine Product and Solutions
Table 57. Konica Minolta Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. LabCorp Corporate Information, Head Office, and Major Competitors
Table 59. LabCorp Major Business
Table 60. LabCorp Oncology Precision Medicine Product and Solutions
Table 61. LabCorp Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. MDxHealth Corporate Information, Head Office, and Major Competitors
Table 63. MDxHealth Major Business
Table 64. MDxHealth Oncology Precision Medicine Product and Solutions
Table 65. MDxHealth Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 67. Myriad Genetics Major Business
Table 68. Myriad Genetics Oncology Precision Medicine Product and Solutions
Table 69. Myriad Genetics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Novartis Corporate Information, Head Office, and Major Competitors
Table 71. Novartis Major Business
Table 72. Novartis Oncology Precision Medicine Product and Solutions
Table 73. Novartis Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. OPKO Health Corporate Information, Head Office, and Major Competitors
Table 75. OPKO Health Major Business
Table 76. OPKO Health Oncology Precision Medicine Product and Solutions
Table 77. OPKO Health Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Pacific Biosciences Corporate Information, Head Office, and Major Competitors
Table 79. Pacific Biosciences Major Business
Table 80. Pacific Biosciences Oncology Precision Medicine Product and Solutions
Table 81. Pacific Biosciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 83. Quest Diagnostics Major Business
Table 84. Quest Diagnostics Oncology Precision Medicine Product and Solutions
Table 85. Quest Diagnostics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Qiagen Corporate Information, Head Office, and Major Competitors
Table 87. Qiagen Major Business
Table 88. Qiagen Oncology Precision Medicine Product and Solutions
Table 89. Qiagen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Global Oncology Precision Medicine Revenue (USD Million) by Players (2019-2021)
Table 91. Global Oncology Precision Medicine Revenue Share by Players (2019-2021)
Table 92. Breakdown of Oncology Precision Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Oncology Precision Medicine Players Head Office, Products and Services Provided
Table 94. Oncology Precision Medicine Mergers & Acquisitions in the Past Five Years
Table 95. Oncology Precision Medicine New Entrants and Expansion Plans
Table 96. Global Oncology Precision Medicine Revenue (USD Million) by Type (2016-2021)
Table 97. Global Oncology Precision Medicine Revenue Share by Type (2016-2021)
Table 98. Global Oncology Precision Medicine Revenue Forecast by Type (2021-2026)
Table 99. Global Oncology Precision Medicine Revenue by Application (2016-2021)
Table 100. Global Oncology Precision Medicine Revenue Forecast by Application (2021-2026)
Table 101. North America Oncology Precision Medicine Revenue by Type (2016-2021) & (USD Million)
Table 102. North America Oncology Precision Medicine Revenue by Type (2021-2026) & (USD Million)
Table 103. North America Oncology Precision Medicine Revenue by Application (2016-2021) & (USD Million)
Table 104. North America Oncology Precision Medicine Revenue by Application (2021-2026) & (USD Million)
Table 105. North America Oncology Precision Medicine Revenue by Country (2016-2021) & (USD Million)
Table 106. North America Oncology Precision Medicine Revenue by Country (2021-2026) & (USD Million)
Table 107. Europe Oncology Precision Medicine Revenue by Type (2016-2021) & (USD Million)
Table 108. Europe Oncology Precision Medicine Revenue by Type (2021-2026) & (USD Million)
Table 109. Europe Oncology Precision Medicine Revenue by Application (2016-2021) & (USD Million)
Table 110. Europe Oncology Precision Medicine Revenue by Application (2021-2026) & (USD Million)
Table 111. Europe Oncology Precision Medicine Revenue by Country (2016-2021) & (USD Million)
Table 112. Europe Oncology Precision Medicine Revenue by Country (2021-2026) & (USD Million)
Table 113. Asia-Pacific Oncology Precision Medicine Revenue by Type (2016-2021) & (USD Million)
Table 114. Asia-Pacific Oncology Precision Medicine Revenue by Type (2021-2026) & (USD Million)
Table 115. Asia-Pacific Oncology Precision Medicine Revenue by Application (2016-2021) & (USD Million)
Table 116. Asia-Pacific Oncology Precision Medicine Revenue by Application (2021-2026) & (USD Million)
Table 117. Asia-Pacific Oncology Precision Medicine Revenue by Region (2016-2021) & (USD Million)
Table 118. Asia-Pacific Oncology Precision Medicine Revenue by Region (2021-2026) & (USD Million)
Table 119. South America Oncology Precision Medicine Revenue by Type (2016-2021) & (USD Million)
Table 120. South America Oncology Precision Medicine Revenue by Type (2021-2026) & (USD Million)
Table 121. South America Oncology Precision Medicine Revenue by Application (2016-2021) & (USD Million)
Table 122. South America Oncology Precision Medicine Revenue by Application (2021-2026) & (USD Million)
Table 123. South America Oncology Precision Medicine Revenue by Country (2016-2021) & (USD Million)
Table 124. South America Oncology Precision Medicine Revenue by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Oncology Precision Medicine Revenue by Type (2016-2021) & (USD Million)
Table 126. Middle East & Africa Oncology Precision Medicine Revenue by Type (2021-2026) & (USD Million)
Table 127. Middle East & Africa Oncology Precision Medicine Revenue by Application (2016-2021) & (USD Million)
Table 128. Middle East & Africa Oncology Precision Medicine Revenue by Application (2021-2026) & (USD Million)
Table 129. Middle East & Africa Oncology Precision Medicine Revenue by Country (2016-2021) & (USD Million)
Table 130. Middle East & Africa Oncology Precision Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oncology Precision Medicine Picture
Figure 2. Global Oncology Precision Medicine Revenue Market Share by Type in 2020
Figure 3. Applied Sciences
Figure 4. Precision Diagnostics
Figure 5. Digital Health and Information Technology
Figure 6. Precision Therapeutics
Figure 7. Oncology Precision Medicine Revenue Market Share by Application in 2020
Figure 8. Breast Cancer Picture
Figure 9. Lung Cancer Picture
Figure 10. Colorectal Cancer Picture
Figure 11. Prostate Cancer Picture
Figure 12. Cervical Cancer Picture
Figure 13. Other Cancer Picture
Figure 14. Global Oncology Precision Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Oncology Precision Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Oncology Precision Medicine Revenue Market Share by Region (2016-2026)
Figure 17. Global Oncology Precision Medicine Revenue Market Share by Region in 2020
Figure 18. North America Oncology Precision Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Oncology Precision Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Oncology Precision Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Oncology Precision Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Oncology Precision Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Oncology Precision Medicine Market Drivers
Figure 24. Oncology Precision Medicine Market Restraints
Figure 25. Oncology Precision Medicine Market Trends
Figure 26. Abbott Laboratories Recent Developments and Future Plans
Figure 27. Agilent Technologies Recent Developments and Future Plans
Figure 28. Almac Recent Developments and Future Plans
Figure 29. ANGLE plc Recent Developments and Future Plans
Figure 30. Asuragen Recent Developments and Future Plans
Figure 31. BGI Group Recent Developments and Future Plans
Figure 32. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 33. BioMérieux Recent Developments and Future Plans
Figure 34. Bristol Myers Squibb Recent Developments and Future Plans
Figure 35. Roche Holding AG Recent Developments and Future Plans
Figure 36. Gilead Sciences Recent Developments and Future Plans
Figure 37. Illumina Recent Developments and Future Plans
Figure 38. Konica Minolta Recent Developments and Future Plans
Figure 39. LabCorp Recent Developments and Future Plans
Figure 40. MDxHealth Recent Developments and Future Plans
Figure 41. Myriad Genetics Recent Developments and Future Plans
Figure 42. Novartis Recent Developments and Future Plans
Figure 43. OPKO Health Recent Developments and Future Plans
Figure 44. Pacific Biosciences Recent Developments and Future Plans
Figure 45. Quest Diagnostics Recent Developments and Future Plans
Figure 46. Qiagen Recent Developments and Future Plans
Figure 47. Global Oncology Precision Medicine Revenue Share by Players in 2020
Figure 48. Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 49. Global Top 3 Players Oncology Precision Medicine Revenue Market Share in 2020
Figure 50. Global Top 10 Players Oncology Precision Medicine Revenue Market Share in 2020
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 52. Global Oncology Precision Medicine Revenue Share by Type in 2020
Figure 53. Global Oncology Precision Medicine Market Share Forecast by Type (2021-2026)
Figure 54. Global Oncology Precision Medicine Revenue Share by Application in 2020
Figure 55. Global Oncology Precision Medicine Market Share Forecast by Application (2021-2026)
Figure 56. North America Oncology Precision Medicine Sales Market Share by Type (2016-2026)
Figure 57. North America Oncology Precision Medicine Sales Market Share by Application (2016-2026)
Figure 58. North America Oncology Precision Medicine Revenue Market Share by Country (2016-2026)
Figure 59. United States Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Canada Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Mexico Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Europe Oncology Precision Medicine Sales Market Share by Type (2016-2026)
Figure 63. Europe Oncology Precision Medicine Sales Market Share by Application (2016-2026)
Figure 64. Europe Oncology Precision Medicine Revenue Market Share by Country (2016-2026)
Figure 65. Germany Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. France Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. United Kingdom Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Russia Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Italy Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Asia-Pacific Oncology Precision Medicine Sales Market Share by Type (2016-2026)
Figure 71. Asia-Pacific Oncology Precision Medicine Sales Market Share by Application (2016-2026)
Figure 72. Asia-Pacific Oncology Precision Medicine Revenue Market Share by Region (2016-2026)
Figure 73. China Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Japan Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Korea Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. India Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Southeast Asia Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Australia Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South America Oncology Precision Medicine Sales Market Share by Type (2016-2026)
Figure 80. South America Oncology Precision Medicine Sales Market Share by Application (2016-2026)
Figure 81. South America Oncology Precision Medicine Revenue Market Share by Country (2016-2026)
Figure 82. Brazil Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Argentina Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Middle East and Africa Oncology Precision Medicine Sales Market Share by Type (2016-2026)
Figure 85. Middle East and Africa Oncology Precision Medicine Sales Market Share by Application (2016-2026)
Figure 86. Middle East and Africa Oncology Precision Medicine Revenue Market Share by Country (2016-2026)
Figure 87. Turkey Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Saudi Arabia Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. UAE Oncology Precision Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source

---